Procter & Gamble (PG) Stock May Be 24% Undervalued After Q1 Sales Slip

Procter & Gamble has delivered a 22.1% total return over the past 5 years, which puts fresh focus on whether the current share price around US$149 is aligned with the cash the business can generate. With a long track record in everyday consumer products and a steady news flow from its related subsidiaries, the question now is how that market performance lines up with the stock's intrinsic value based on its cash flows.

• The 22.1% gain over 5 years means long term holders are sitting on a meaningful profit. The key issue is whether those gains are supported by the cash the business can produce over time.
• Recent commentary from Procter & Gamble Hygiene and Health Care on softer sales in India, shifting demand and commodity cost volatility highlights how changing consumer patterns and input prices can influence expectations for future cash generation and capital needs across the wider group.
• What if you looked at Procter & Gamble through its earnings instead? See what Procter & Gamble's 22.0x P/E says about the price.

The stock's next move may depend on whether the current price is in line with what Procter & Gamble's cash flows suggest when run through a Discounted Cash Flow model.

If you want more starting points beyond Procter & Gamble for assessing whether cash flows justify current pricing, a focused screen of 32 high quality undervalued stocks can help shape your watchlist.

Does Procter & Gamble Look Undervalued on Cash Flow?

The Discounted Cash Flow (DCF) model looks at the cash Procter & Gamble can return to shareholders over time and discounts it back to today. On the latest figures, the group produced about $15.6b of free cash flow over the last twelve months, and analysts expect that pool of cash to grow steadily rather than surge or shrink. That kind of profile fits a mature consumer products business where the focus is on consistency instead of big swings.

The projections behind this DCF lean on relatively modest growth in free cash flow through the next decade, yet they still put Procter & Gamble's estimated intrinsic value meaningfully above the current share price of $149.03. The recent 5% year over year sales decline at Procter & Gamble Hygiene and Health Care in India, tied to demand shifts and commodity volatility, helps explain why the market price may lag what the wider group's cash flows imply. To see how those projections translate into an estimated per share value, you can review the full DCF inputs and outcome in the detailed valuation breakdown. Find out what Procter & Gamble could be worth using our Discounted Cash Flow (DCF) estimate.

The Procter & Gamble Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the Procter & Gamble valuation puzzle leaves off by explaining which assumptions about future growth, profitability and earnings would need to hold for the shares to be worth materially more or materially less than today’s price. Each narrative ties its number to a concrete view of how Procter & Gamble's growth path, margins and risk profile might evolve, giving you a reference point you can revisit as new information emerges.

Community views on Procter & Gamble are split between those who see solid fundamentals being underappreciated and others who think the valuation already reflects too much optimism.

Bull case: roughly fairly valued

"PG’s current P/E ratio of about 20× also looks modest for a company with its brand strength and earnings consistency..."

Discover why this Narrative puts Procter & Gamble at roughly fairly valued.

Bear case: 39% overvalued

"From these simulations we can extrapolate that there is more than ~90% probability of Procter & Gamble being overvalued..."

Explore why this Narrative puts Procter & Gamble at 39% overvalued.

One more angle on Procter & Gamble worth checking

Valuation only tells part of the story for Procter & Gamble, since recent trades by company insiders can reveal how executives and directors are acting with their own capital. See the recent insider selling flagged for Procter & Gamble.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com